• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Filaria in Ghana – Slideshow

Home > News

Filaria in Ghana – Slideshow

Dr. Linda Batsa Debrah examines Ama Dadiesa, 61, who has LF, causing swelling and "mossy" skin on her leg. Because of her condition, her husband divorced her and abandoned her and her children.
18 Jun 2014

Filaria is a group of neglected tropical diseases infecting over 150 million people in sub-Saharan Africa, Asia, and Latin America. The two main filarial diseases, onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis), devastate the lives of patients, causing debilitating symptoms and social discrimination. In March 2014, DNDi traveled to rural Ghana to meet and interview patients with filaria and the physician-researchers treating them.

River near Mankattah village, Dunkwa district, southern Ghana, an area endemic for onchocerciasis (river blindness). The black flies that transmit onchocerciasis are believed to breed in the river.
Setting up a medical examination tent in Mankattah village, Dunkwa district, southern Ghana, an area endemic for onchocerciasis (river blindness).
Medical research team from KCCR (Kumasi, Ghana), explaining the day’s activities to patients, Mankattah village. Speaking: Research Assistant Yusif Mubarik; seated: Prof. Achim Hoerauf (left), Dr. Alexander Debrah (right).
Dr. Alexander Debrah points to skin nodule on Kwame Michael Ntumi, 48, who has onchocerciasis. The nodule contains many adult filarial worms, which can live for 15 years.
Dr. Linda Batsa Debrah (left) with Gladys Bediako, 30, a patient with onchocerciasis from Mankattah village. Ms. Bediako suffers intense itching and body pain, often preventing her from working.
“Leopard skin” (discoloration of the skin) due to onchocerciasis is visible on these patients’ legs. This condition can cause social stigmatization and embarrassment for the patient.
View of Asemkow, a coastal village in Ghana, where lymphatic filariasis (LF, or elephantiasis) is endemic. Most of the people in Asemkow village make a living through catching and selling fish.
Dr. Linda Batsa Debrah examines Ama Dadiesa, 61, who has LF, causing swelling and “mossy” skin on her leg. Because of her condition, her husband divorced her and abandoned her and her children.
Adwoa Mamsowaa, 49, from the nearby village of Asemasa, has LF, causing massive swelling of her leg and recurrent attacks of body pain. When these attacks occur, she is not able to work.
Drawing blood to test for LF, in Asemkow village. Doctors use a rapid diagnostic immunochromatographic test (ICT) that can give a result in just a few hours.
Distribution of bowls and disinfectant soap to LF patients to wash and clean their limbs, to prevent infections.
Nighttime blood draw, Busua village, Ghana. Doctors examine the blood through a microscope to look for moving LF worms, which are most actively transmitted at night.
Lab technologists extracting DNA from filarial worms, at KCCR (Kumasi Centre for Collaborative Research in Tropical Medicine), Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
Dr. Alexander Debrah, co-lead researcher of the Filariasis Project at KCCR (Kumasi, Ghana), examines a filarial worm sample in a microscope at the university’s parasitology lab.

All photos, credit ©: DNDi/Cosmos/Sylvain Cherkaoui

Policy advocacy Filaria: river blindness

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License